A02-K03 菅波 孝祥(名古屋大学 環境医学研究所)
- Y. Kanamori, M. Tanaka, M. Itoh, K. Ochi, A. Ito, I. Hidaka, I. Sakaida, Y. Ogawa, T. Suganami: “Iron-rich Kupffer Cells Exhibit Phenotypic Changes during the Development of Liver Fibrosis in NASH” iScience 24, 102032 (2021) DOI: https://doi.org/10.1016/j.isci.2020.102032
- M. Tanaka, M. Saka-Tanaka, K. Ochi, K. Fujieda, Y. Sugiura, T. Miyamoto, H. Kohda, A. Ito, T. Miyazawa, A. Matsumoto, S. Aoe, Y. Miyamoto, N. Tsuboi, S. Maruyama, M. Suematsu, S. Yamasaki, Y. Ogawa, T. Suganami. “C-type Lectin Mincle Mediates Cell Death–triggered Sustained Inflammation in Acute Kidney Injury.” J. Exp. Med. 217, e20192230 (2020) DOI: https://doi.org/10.1084/jem.20192230
- K. Kurita, H. Ohta, I. Shirakawa, M. Tanaka, Y. Kitaura, Y. Iwasaki, T. Matsuzaka, H. Shimano, S. Aoe, H. Arima, Y. Ogawa, A. Ito, T. Suganami: “Macrophages Rely on Extracellular Serine to Suppress Aberrant Cytokine Production” Sci. Rep. 11, 11137 (2021) DOI: https://doi.org/10.1038/s41598-021-90086-w
- N. Yoshioka, M. Tanaka, K. Ochi, A. Watanabe, K. Ono, M. Sawada, T. Ogi, M. Itoh, A. Ito, Y. Shiraki, A. Enomoto, M. Ishigami, M. Fujishiro, Y. Ogawa, T. Suganami: “The Sodium-glucose Cotransporter-2 Inhibitor Tofogliflozin Prevents the Progression of Nonalcoholic Steatohepatitis–associated Liver Tumors in a Novel Murine Model” Biomed. Pharmacother. 140, 111738 (2021) DOI: https://doi.org/10.1016/j.biopha.2021.111738
- A. Kobayashi, A. Ito, I. Shirakawa, A. Tamura, S. Tomono, H. Shindou, P. Niklas Hedde, M. Tanaka, N. Tsuboi, T. Ishimoto, S. Akashi-Takamura, S. Maruyama, T. Suganami: “Dietary Supplementation with Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity” Front. Immunol. 12, 650856 (2021) DOI: https://doi.org/10.3389/fimmu.2021.650856
- T. Inoue, B. Fu, M. Nishio, M. Tanaka, H. Kato, M. Tanaka, M. Itoh, H. Yamakage, K. Ochi, A. Ito, Y. Shiraki, S. Saito, M. Ihara, H. Nishimura, A. Kawamoto, S. Inoue, K. Saeki, A. Enomoto, T. Suganami, N. Satoh-Asahara: “Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis” Nutrients 15, 350 (2023) DOI: https://doi.org/10.3390/nu15020350
- M. Itoh, A. Tamura, S. Kanai, M. Tanaka, Y. Kanamori, I. Shirakawa, A. Ito, Y. Oka, I. Hidaka, T. Takami, Y. Honda, M. Maeda, Y. Saito, Y. Murata, T. Matozaki, A. Nakajima, Y. Kataoka, T. Ogi, Y. Ogawa, T. Suganami. “Lysosomal Cholesterol Overload Triggers Macrophage Phenotypic Changes and Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.” J. Exp. Med. 220, e20220681 (2023) DOI: https://doi.org/10.1084/jem.20220681
